KAPA (Kairos Pharma) Accounts Payable: $0.43 Mil (As of Mar. 2026)


KAPA Kairos Pharma Ltd KAPA
15 GF Score
Price $0.39
View Full Analysis

What is Kairos Pharma Accounts Payable?

Kairos Pharma KAPA +5.11% 15 Accounts Payable is $0.43 Mil as of Mar. 2026. GuruFocus rates KAPA with a GF Score™ of 15/100.

Kairos Pharma's Accounts Payable for the quarter that ended in Mar. 2026 was $0.43 Mil.

Kairos Pharma's quarterly Accounts Payable increased from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.20 Mil) and increased from Dec. 2025 ($0.20 Mil) to Mar. 2026 ($0.43 Mil).

Kairos Pharma's annual Accounts Payable declined from Dec. 2023 ($2.40 Mil) to Dec. 2024 ($0.99 Mil) and declined from Dec. 2024 ($0.99 Mil) to Dec. 2025 ($0.20 Mil).

Kairos Pharma Accounts Payable Related Terms

Kairos Pharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for Kairos Pharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kairos Pharma Accounts Payable Chart

Kairos Pharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 1.55 1.63 2.40 0.99 0.20

Kairos Pharma Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.68 0.00 0.20 0.43
KAPA
15GF Score
Kairos Pharma Ltd KAPA
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kairos Pharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.43 Mil mean?
Kairos Pharma (KAPA) has a Accounts Payable of $0.43 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Kairos Pharma and its competitors.
Is Kairos Pharma's Accounts Payable too high?
Kairos Pharma's current Accounts Payable is $0.43 Mil. Overall, Kairos Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Kairos Pharma's Accounts Payable compare to IMNN and HCWB?
Kairos Pharma's Accounts Payable of $0.43 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Kairos Pharma and its competitors. Kairos Pharma's current Accounts Payable is $0.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kairos Pharma stock overvalued right now?
Kairos Pharma (KAPA) has a current Accounts Payable of $0.43 Mil. The current Accounts Payable is $0.43 Mil. Kairos Pharma's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Kairos Pharma (KAPA), the current Accounts Payable is $0.43 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kairos Pharma Business Description

Address 2355 Westwood Boulevard, No. 139, Los Angeles, CA, USA, 90064
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
15GF Score

Get the complete analysis for KAPA

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.39
Price